Safety of direct injection of oligodendrocyte progenitor cells into the spinal cord of uninjured Göttingen minipigs.

Fessler, Richard G; Liu, Charles Y; McKenna, Stephen; Fessler, R David; Lebkowski, Jane S; Priest, Catherine A; Wirth, Edward D

Fessler, Richard G; Liu, Charles Y; McKenna, Stephen; Fessler, R David; Lebkowski, Jane S; Priest, Catherine A; Wirth, Edward D.

Afiliación

Fessler RG; 1Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois.
Liu CY; 2USC Neurorestoration Center, Los Angeles.
McKenna S; 3Department of Neurosurgery, Stanford University, Palo Alto; and.
Fessler RD; 1Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois.
Lebkowski JS; 4Asterias Biotherapeutics, a wholly owned subsidiary of Lineage Cell Therapeutics, Carlsbad, California.
Priest CA; 4Asterias Biotherapeutics, a wholly owned subsidiary of Lineage Cell Therapeutics, Carlsbad, California.
Wirth ED; 4Asterias Biotherapeutics, a wholly owned subsidiary of Lineage Cell Therapeutics, Carlsbad, California.

J Neurosurg Spine ; 35(3): 389-397, 2021 Jul 09.

Article en En | MEDLINE | ID: mdl-34243160

Palabras clave

oligodendrocyte progenitor cells; spinal cord injury; stem cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Neurosurg Spine Asunto de la revista: NEUROCIRURGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google